A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer
Phase 2
60
about 5.1 years
18–70
Female only
12 sites in AZ, CA, FL +8
Why this study is shown
What this study is about
Researchers are testing a treatment called lifileucel for adults with advanced endometrial cancer. The trial will last about 1858 days and aims to see if this treatment is effective and safe.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Lifileucel
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
lifileucel
Primary: Objective Response Rate
Secondary: Adverse Events, Complete Response Rate, Disease Control Rate, Duration of Response, Overall Survival, Progression-Free Survival
Oncology